Skip to main content
PMC home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2003 Nov 7;17(6):209–215. doi: 10.1002/jcla.10093

Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)‐infected Chilean patients

Iván Palomo 1,✉, Marcelo Alarcón 1, Cecilia Sepulveda 2, Jaime Pereira 3, Ricardo Espinola 4, Silvia Pierangeli 4,†
PMCID: PMC6808167  PMID: 14614742

Abstract

Antiphospholipid (aPL) and antiplatelet (aPlt) antibodies, found in patients with autoimmune diseases, are also detected in infectious diseases. The purpose of this study was to examine the prevalence of these antibodies in HIV patients and to evaluate an association of these antibodies with thrombocytopenia and/or thrombosis. Sixty‐three HIV‐seropositive patients and 52 normal controls were studied. Anti‐cardiolipin (aCL), anti‐β2 glycoprotein I (anti‐β2GPI), and antiprothrombin (aPT) antibodies were determined and the lupus anticoagulant (LA) test was performed. Antiplatelet antibodies (aPlt) were also determined. Seven out of 63 (12.7%) HIV patients were positive for aCL, four of 63 (6.3%) for anti‐β2GPI, and five of 63 (7.9%) for aPT. No patients studied were LA positive. Six out of 63 (9.5%) patients were positive for aPlt. One of them showed weak reactivity for GPIb‐IX. The platelet count of patients (202±63×103 platelets/μL) was significantly lower than in the controls (343±6×103 platelets/μL) (P<0.001). There was no correlation between the presence of aPL and/or aPlt and thrombocytopenia. Of the HIV‐infected patients, 22.2% presented aPL and 9.4% aPlt antibodies. In this study, the presence of aPL and aPlt antibodies was not associated with the development of thrombosis and/or thrombocytopenia. J. Clin. Lab. Anal. 17:209–215, 2003. © 2003 Wiley‐Liss, Inc.

Keywords: HIV infection, antiphospholipid antibodies, antiplatelet antibodies, anti‐cardiolipin antibodies

REFERENCES

  • 1. Hughes G, Harris E, Gharavi A. The anticardiolipin syndrome. J Rheumatol 1986;13:486–489. [PubMed] [Google Scholar]
  • 2. Asherson R, Cervera R, Piette JC, Shoenfeld Y. The antiphospholipid syndrome: history, definition, classification and differential diagnosis In: Asherson R, Cervera R, Piette JC, Shoenfeld Y, editors. The antiphospholipid syndrome. New York: CRC Press; 1996. p 3–12. [Google Scholar]
  • 3. He R, Reid DM, Jones CE, Shulman NR. Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood 1994;83:1024–1032. [PubMed] [Google Scholar]
  • 4. Shulman R, Reid DM. Platelet immunology In: Colman R, Hirsh J, Marder V, Salzman E, editors. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia, PA: Lippincott Company; 1994. p 414–468. [Google Scholar]
  • 5. Rand ML, Wright JF. Idiopathic thrombocytopenic purpure virus‐associated. Transfus Sci 1998;19:253–259. [DOI] [PubMed] [Google Scholar]
  • 6. Roubey RA. Immunology of the antiphospholipid syndrome: antibodies, antigens, and autoimmune response. Thromb Haemost 1999;82:656–661. [PubMed] [Google Scholar]
  • 7. Pierangeli S, Gharavi AE, Harris EN. Anticardiolipin testing In: Kamashta MA, editor. Hughes syndrome, antiphospholipid syndrome. London: Springer; 2000. p 205–212. [Google Scholar]
  • 8. Mackie IJ, Donohe S, Machin SJ. Lupus anticoagulant measurement In: Kamashta MA, editor. Hughes syndrome, antiphospholipid syndrome. London: Springer; 2000. p 214–224. [Google Scholar]
  • 9. de Larranaga GF, Forastiero RR, Carreras LO, Alonso BS. Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome. Thromb Res 1999;96:19–25. [DOI] [PubMed] [Google Scholar]
  • 10. Galvez J, Martin I, Medino D, Pujol E. Thrombophebitis in a patients with abute Q fever and anticardiolipin antibodies. Med Clin (Barc)(Barc) 1998. 108:396–397. [PubMed] [Google Scholar]
  • 11. Mackworth‐Young CG, Harris EN, Steere AC, et al. Anticardiolipin antibodies in Lyme disease. Arthritis Rheum 1998;31:1052–1056. [DOI] [PubMed] [Google Scholar]
  • 12. Catteau B, Delaporte E, Hachulla E, Piette F, Bergoend H. Mycoplasma infection with Stevens Johnson syndrome and antiphospholipid antibodies. apropos of 2 cases. Rev Med Interne 1995;16:10–14. [DOI] [PubMed] [Google Scholar]
  • 13. Santiago MB, Cossermelli W, Tuma MF, Pinto MN, Oliveira RM. Anticardiolipin antibodies in patients with infectious diseases. Clin Rheumatol 1989;8:23–28. [DOI] [PubMed] [Google Scholar]
  • 14. Fiallo P, Travaglino C, Nunzi E, Cardo PP. β2‐Glycoprotein I‐dependence of anticardiolipin antibodies in multibacillary leprosy patients. Lepr Rev 1998;69:376–381. [DOI] [PubMed] [Google Scholar]
  • 15. Petrovas C, Vlachoyiannopoulos PG, Kordossis T, Moutsopoulos HM. Anti‐phospholipid antibodies in HIV infection and SLE with or without anti‐phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with β2‐GPI. J Autoimmun 1999;13:347–355. [DOI] [PubMed] [Google Scholar]
  • 16. Cheng HM, Khairullah NS. Induction of antiphospholipid autoantibody during cytomegalovirus infection. Clin Infect Dis 1997;25:1493–1494. [DOI] [PubMed] [Google Scholar]
  • 17. Manco‐Johnson MJ, Nuss R, Key N, et al. Lupus anti‐coagulant and protein S deficiency in children with post‐varicella purpura fulminans or thrombosis. J Pediatr 1996;128:319–23. [DOI] [PubMed] [Google Scholar]
  • 18. Leroy V, Arvieux J, Jacob MC, Maynard‐Muet M, Baud M, Zarski JP. Prevalence and significance of anticardiolipin, anti‐β2 glycoprotein I and anti‐prothrombin antibodies in chronic hepatitis C. Br J Haematol 1998;101:468–474. [DOI] [PubMed] [Google Scholar]
  • 19. Sorice M, Pittoni V, Griggi T, et al. Specificity of antiphospholipid antibodies in infectious mononucleosis: a role for anti‐cofactor protein antibodies. Clin Exp Immunol 2000;120:301–306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Constans J, Guerin V, Couchouron A, et al. Autoantibodies directed against phospholipids or human β2‐glycoprotein I in HIV‐seropositive patients: relationship with endothelial activation and antimalonic dialdehyde antibodies. Eur J Clin Invest 1998;28:115–122. [DOI] [PubMed] [Google Scholar]
  • 21. Matsuda J, Saitoh N, Tsukamoto M, Gohchi K, Asami K, Hashimoto M. Measurement of β2‐glycoprotein I (apolipoprotein H)‐independent anticardiolipin antibody in human immunodeficiency virus‐1‐positive and ‐negative hemophiliacs. Am J Hematol 1993;43:146–148. [DOI] [PubMed] [Google Scholar]
  • 22. Capel P, Janssens A, Clumeck N, et al. Anticardiolipin antibodies (ACA) are most often not associated with lupus anticoagulan (LAC) in human immunodeficiency virus (HIV) infection. Am J Hematol 1991;37:234–238. [DOI] [PubMed] [Google Scholar]
  • 23. Weiss L, You JF, Giral P, Alhenc‐Gelas M, Senger D, Kazatchkine MD. Anti‐cardiolipin antibodies are associated with anti‐endothelial cell antibodies but not with anti‐β2 glycoprotein I antibodies in HIV infection. Clin Immunol Immunopathol 1995;77:69–74. [DOI] [PubMed] [Google Scholar]
  • 24. Abuaf N, Laperche S, Rajoely B, et al. Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost 1997;77:856–861. [PubMed] [Google Scholar]
  • 25. Ankri A, Bonmarchand M, Coutellier A, Herson S, Karmochkine M. Antiphospholipid antibodies are an epiphenomenon in HIV‐infected patients. AIDS 1999;13:1282–1283. [DOI] [PubMed] [Google Scholar]
  • 26. Magnac C, de Saint Martin J, Pidard D, Legrand C, Dighiero G. Platelet antibodies in serum of patients with human immunodeficiency virus (HIV) infection. AIDS Res Hum Retroviruses 1990;6:1443–1449. [DOI] [PubMed] [Google Scholar]
  • 27. Riccio A, Natale D, Fratellanza G, et al. The lack of correlation between the positivity of antiplatelet antibodies and the presence of thrombocytopenia in course of HIV infection. Boll Soc Ital Biol Sper 1993;69:203–208. [PubMed] [Google Scholar]
  • 28. Belmonte MA, Garcia‐Portales R, Domenech I, Fernandez‐Nebro A, Camps MT, De Ramon E. Avascular necrosis of bone in human immunodeficiency virus infection and antiphospholipid antibodies. J Rheumatol 1993;20:1425–1428. [PubMed] [Google Scholar]
  • 29. Thirumalai S, Kirshner HS. Anticardiolipin antibody and stroke in an HIV‐positive patient. AIDS 1994;8:1019–1020. [DOI] [PubMed] [Google Scholar]
  • 30. Louache F, Vainchenker W. Thrombocytopenia in HIV infection. Curr Opin Hematol 1994;1:369–372. [PubMed] [Google Scholar]
  • 31. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN. Measurement of anticardiolipin antibodies by enzyme‐linked immunosobent assay ELISA: standarization and quantitation of results. Clin Exp Immunol 1985;62:738–45. [PMC free article] [PubMed] [Google Scholar]
  • 32. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74:1–9. [DOI] [PubMed] [Google Scholar]
  • 33. Reber G, Arvieux J, Comby E, et al. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe(Groupe d'Etudes sur l'Hemostase et la Thrombose). Thromb Haemost 1995;73:444–452. [PubMed] [Google Scholar]
  • 34. Schleider M, Nachman R, Jaffe E, Coleman M. A clinical study of the lupus anticoagulant. Blood 1976;48:499–509. [PubMed] [Google Scholar]
  • 35. Exner T, Richard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978;40:143–151. [DOI] [PubMed] [Google Scholar]
  • 36. Vasquez‐Mellado J, Llorent L, Alarcon‐Segovia O. Exposure of anionic phospholipid upon platelets activation permits binding of β2GPI and throughs that of IgG antiphospholipid anti‐bodies. Studies in platelets from patients with antiphos‐pholipid syndrome and normal subjects. J Autoimmun 1994;7:335–348. [DOI] [PubMed] [Google Scholar]
  • 37. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995;74:1120–1125. [PubMed] [Google Scholar]
  • 38. Winiarski J, Ekelund E. Antibody binding to platelet in acute and chronic idiopathic thrombocytopenic purpura: a platelet membrane ELISA for the detection of antiplatelet antibodies in serum. Clin Exp Immunol 1987;63:459–465. [PMC free article] [PubMed] [Google Scholar]
  • 39. Furihata K, Nugent D, Bissonette A, Aster R, Kunicki T. On association of platelet specific alloantigen, pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. J Clin Invest 1987;80:1624–1630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Gonzalez‐Conejero R, Rivera J, Rosillo MC, Cano A, Rodriguez T, Vicente V. Association of autoantibodies against platelet glycoproteins Ib/IX and IIb/IIIa, and platelet‐reactive anti‐HIV antibodies in thrombocytopenic narcotic addicts. Br J Haematol 1996;93:464–471. [DOI] [PubMed] [Google Scholar]
  • 41. Palomo I, Pereira J, Alarcón M, et al. Antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus. J Lab Clin Med 2002;140:336–341. [DOI] [PubMed] [Google Scholar]
  • 42. Toulon P. Hemostasis and human immunodeficiency virus (HIV) infection. Ann Biol Clin 1998;56:253–260. [PubMed] [Google Scholar]
  • 43. Santiago M, Martinelli R, Ko A, et al. Anti‐β2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala‐azar. Clin Exp Rheumatol 2001;19:425–430. [PubMed] [Google Scholar]
  • 44. Keeling DM, Birley H, Machin SJ. Multiple transient ischaemic attacks and a mild thrombotic stroke in a HIV‐positive patient with anticardiolipin antibodies. Blood Coagul Fibrinolysis 1990;1:333–335. [DOI] [PubMed] [Google Scholar]
  • 45. Orbea‐Rios L, Venero Gomez J, Justo Alpanes E, Colmenero Camacho M, Rodriguez Pinero J. Deep venous thrombosis of inferior extremity in a patient with AIDS and anticardiolipin antibodies. An Med Interna 1999;16:268. [PubMed] [Google Scholar]
  • 46. Leder AN, Flansbaum B, Zandman‐Goddard G, Asherson R, Shoenfeld Y. Antiphospholipid syndrome induced by HIV. Lupus 2001;10:370–374. [DOI] [PubMed] [Google Scholar]
  • 47. Murphy MF, Metcalfe P, Waters AH, et al. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 1987;66:337–340. [DOI] [PubMed] [Google Scholar]
  • 48. Rossi G, Gorla R, Stellini R, et al. Prevalence, clinical and laboratory features of thrombocytopenia in individuals HIV‐infected. AIDS Res Hum Retroviruses 1990;6:261–269. [DOI] [PubMed] [Google Scholar]
  • 49. Perkocha LA, Rodgers GM. Hematologic aspects of human immunodeficiency virus infection: laboratory and clinical consideration. Am J Hematol 1988;29:94–105. [DOI] [PubMed] [Google Scholar]
  • 50. Walsh CM, Nardi MA, Karpatkin S. On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N Engl J Med 1984;311:635–639. [DOI] [PubMed] [Google Scholar]
  • 51. Karpatkin S, Nardi M. Autoimmune anti‐HIV‐1gp120 antibody with antiidiotype‐like activity in sera and immune complexes of HIV‐1‐related immunologic thrombocytopenia. J Clin Invest 1992;89:356–364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Karpatkin S, Nardi M, Green D. Platelet and coagulation defects associated with HIV‐1‐infected. Thromb Haemost 2002;88:389–401. [PubMed] [Google Scholar]
  • 53. Bettaieb F, Oksenhendler E, Duedardi N, Bierling P. Cross‐reactive antibodies between HIV‐GP120 and plateles GP IIIa (CD61) in HIV‐related inmune trombocytopenic purpura. Clin Exp Immunol 1996;103:19–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Dominguez V, Gevorkian G, Govezensky T, et al. Antigenic homology of HIV‐1 GP 41 and human platelet glycoprotein GP IIIa (integrin β3). J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:385–390. [DOI] [PubMed] [Google Scholar]
  • 55. Chia WK, Blanchette V, Mody M, Wright JF, Freedman J. Characterization of HIV‐1‐specific antibodies and HIV‐1‐crossreactive antibodies to platelets in HIV‐1‐infected haemophiliac patients. Br J Haematol 1998;103:1014–1022. [DOI] [PubMed] [Google Scholar]
  • 56. Palomo I, Pereira J, Alarcon M, Larrain AM, Pinochet C, Vasquez M, Velez MT, Leon M, Espinola R, Pierangeli S. Antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus. J Lab Clin Med 2002;140:336–341. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES